Dischem

For the interim period ended 31 August, revenue grew 9.4% to R17.9bn. Retail revenue +8.1% to R15.6 bn and pharmacy revenue +5.9%. Total income +5.1% to R5.4bn with the margin squeeze to 30.5% from a prior 31.7%. HEPS -17.2% to 58.2 cents. Expenses +9.4%, and Net financing costs +33.2%. Divi -17.3% to 23c a share.
Click here to read the SENS